Institutions added 5.9% to their holdings in the quarter ending June 2026 (9 bought, 18 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$8.38+2.8% that day
Company value
$38M
Share price times all shares
Price vs sales
0.43x
No profit over the last year, so this compares value with sales instead
Cash vs value
17%
Cash as a share of company value
Debt vs value
94%
Debt as a share of company value
From HBIO's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26
$22.7M+11% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $87.8M, down 1.1% from the 12 months before. Over 5 years, sales shrank about 3.3% a year.
What the price assumes
Your guesses, our math
Move the sliders to your own view of HBIO. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
Sales in 5 years$84M
Profit in 5 years$8M
Price these guesses point to$24.92+197% vs $8.38 todayAbout +24% a year, before dividends
What today's price needs: with a 10% margin and a 15x P/E, sales could shrink about 20% a year for 5 years and still match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.